BioCentury
ARTICLE | Politics & Policy

FDA deputy Califf's consulting reported

July 1, 2015 1:41 AM UTC

Robert Califf received about $25,000 for consulting for five pharma companies in 2014 prior to his appointment as FDA deputy commissioner for medical products and tobacco, according to a physician payments database CMS released Tuesday. According to the database, Califf contributed all of the fees to third parties. In financial disclosure sections of published papers, Califf has reported that he donated all income from consulting activities to not-for-profit organizations.

Califf consulted in 2014 for Amgen Inc. (NASDAQ:AMGN), Daiichi Sankyo Co. Ltd. (Tokyo:4568), Roche (SIX:ROG; OTCQX:RHHBY), Merck & Co. Inc. (NYSE:MRK) and Sanofi (Euronext:SAN; NYSE:SNY). Califf also received about $4,000 in reimbursement for travel expenses from the five companies in 2014. ...